JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 45 filers reported holding JANUX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,372,243 | -88.4% | 452,590 | -88.2% | 0.13% | -91.2% |
| Q1 2023 | $46,445,681 | +148.1% | 3,838,486 | +170.1% | 1.50% | +162.5% |
| Q4 2022 | $18,718,771 | -2.7% | 1,421,319 | 0.0% | 0.57% | +0.4% |
| Q3 2022 | $19,245,000 | +10.9% | 1,421,319 | 0.0% | 0.57% | -5.2% |
| Q2 2022 | $17,354,000 | -14.9% | 1,421,319 | 0.0% | 0.60% | -6.1% |
| Q1 2022 | $20,382,000 | -26.8% | 1,421,319 | +0.7% | 0.64% | -28.2% |
| Q4 2021 | $27,858,000 | -8.8% | 1,411,975 | 0.0% | 0.89% | -16.4% |
| Q3 2021 | $30,541,000 | -13.3% | 1,411,975 | 0.0% | 1.06% | -19.4% |
| Q2 2021 | $35,229,000 | – | 1,411,975 | – | 1.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $216,333,000 | 3.47% |
| 5AM Venture Management, LLC | 446,266 | $11,134,000 | 2.80% |
| Samsara BioCapital, LLC | 607,949 | $15,168,000 | 1.87% |
| EcoR1 Capital, LLC | 1,411,975 | $35,229,000 | 1.32% |
| Logos Global Management LP | 547,122 | $13,651,000 | 1.15% |
| BVF INC/IL | 1,176,681 | $29,358,000 | 1.10% |
| Orbimed Advisors | 3,466,386 | $86,486,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 700,000 | $17,465,000 | 0.31% |
| Pinz Capital Management, LP | 32,100 | $801,000 | 0.24% |
| Woodline Partners LP | 334,260 | $8,340,000 | 0.16% |